We have collected SAXS curves for two multiprotein complexes (C1 and C2) where each complex is a specific combination of two kinds of Protomers (P1 and P2). P1 and P2 are well-folded structures and their atomic coordinates can be treated as rigid bodies. Both C1 and C2 can be thought of as a string of protomers from N- to C-terminus, where adjacent protomers are connected by flexible linkers of 15 amino acids. The sequence of protomers in C1 and C2 are ‘P1—P1—P2—P1—P1’ and ‘P1—P2—P1’ respectively. C2 is a subset of C1 in solution. Additionally we have collected a third SAXS curve of multiprotein complex3 (C3) that is composed of two sets of C2 (C2 forms stable dimers under certain conditions). There are no linker restrains between the two sets of C2 in C3 as the interaction between the sets is purely electrostatic in solution.

Taken together, C2 is a subset of both C1 and C3. The structural arrangement of the protomers in C2 is preserved in C1 and C3. Since there is a presumed C2 commonality between the three multiprotein complexes, we consider it best to refine C1, C2 and C3 simultaneously as it provides cross validation across the incremental steps of the refinement process.

Our program of choice so far is CORAL. We were successful in refining C1 and C2 simultaneously. The PDB of C1 (P1—P1—P2—P1—P1) was represented as a single chain and the middle constituents (P1—P2—P1) between the flanking P1 protomers were defined as C2. In this instance, the input files were a single PDB and two SAXS curves of C1 and C2. We are at a loss for a method to incorporate the SAXS curve of C3. One possibility is to somehow define C3 as two sets of C2 and note the absence of linker constrains between the sets, in which case the input for refinement will consist of the original PDB and 3 SAXS curves. Another possibility is to represent C3 in a separate PDB where each set of C2 is specified in a discrete chain, in which case the input for refinement will consist of two PDBs and 3 SAXS curves. In any case we lack the CORAL-proficiency in testing these possibilities. All help is welcome and most appreciated.

Amongst other things, we have no knowledge of the symmetries in the above complexes. Kratky analysis along with a variety of biophysical and biochemical data assures us of the structural stability and the stoichiometry of the multiprotein complexes.


--
Balendu Avvaru
Postdoctoral Fellow
Cytoskeletal dynamics and Motility
Laboratory of Structural Enzymology and Biochemistry (LEBS)
CNRS Bâtiment 34, Avenue de la Terrasse
FRANCE 91198

Reply via email to